Bing Lu

1.6k total citations
34 papers, 771 citations indexed

About

Bing Lu is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Bing Lu has authored 34 papers receiving a total of 771 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Bing Lu's work include Epigenetics and DNA Methylation (5 papers), Histone Deacetylase Inhibitors Research (3 papers) and Cancer-related molecular mechanisms research (3 papers). Bing Lu is often cited by papers focused on Epigenetics and DNA Methylation (5 papers), Histone Deacetylase Inhibitors Research (3 papers) and Cancer-related molecular mechanisms research (3 papers). Bing Lu collaborates with scholars based in China, United States and United Kingdom. Bing Lu's co-authors include Wei Zhao, Ronald S. Weinstein, Warren Knudson, John S. Coon, Jingxin Mo, Xiaojia Huang, Changye Zou, Jincan He, Yangyang He and Jiaming Yu and has published in prestigious journals such as Journal of Clinical Investigation, The FASEB Journal and Journal of Medicinal Chemistry.

In The Last Decade

Bing Lu

33 papers receiving 762 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bing Lu China 16 382 201 95 95 92 34 771
Marit Liland Sandvold Netherlands 15 462 1.2× 222 1.1× 40 0.4× 116 1.2× 76 0.8× 27 725
Florence Gattacceca France 15 326 0.9× 106 0.5× 66 0.7× 39 0.4× 67 0.7× 33 809
J. H. Beijnen Netherlands 17 320 0.8× 295 1.5× 40 0.4× 100 1.1× 41 0.4× 40 797
Lela Buckingham United States 17 505 1.3× 353 1.8× 175 1.8× 55 0.6× 122 1.3× 48 983
Mukul Minocha United States 13 151 0.4× 256 1.3× 84 0.9× 53 0.6× 29 0.3× 32 612
Chunmei Xie China 14 274 0.7× 63 0.3× 140 1.5× 50 0.5× 102 1.1× 27 584
Banmeet S. Anand United States 20 344 0.9× 386 1.9× 53 0.6× 103 1.1× 22 0.2× 38 1.0k

Countries citing papers authored by Bing Lu

Since Specialization
Citations

This map shows the geographic impact of Bing Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing Lu more than expected).

Fields of papers citing papers by Bing Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bing Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing Lu. The network helps show where Bing Lu may publish in the future.

Co-authorship network of co-authors of Bing Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Bing Lu. A scholar is included among the top collaborators of Bing Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bing Lu. Bing Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Jiaming, Chuanxia Zhang, Bing Lu, et al.. (2025). AZIN1-dependent polyamine synthesis accelerates tumor cell cycle progression and impairs effector T-cell function in osteosarcoma. Cell Death and Disease. 16(1). 310–310. 2 indexed citations
2.
3.
Lu, Bing, Li Wang, Mingsen Li, et al.. (2024). Phase separation of phospho-HDAC6 drives aberrant chromatin architecture in triple-negative breast cancer. Nature Cancer. 5(11). 1622–1640. 20 indexed citations
4.
Zheng, Jim, Bing Lu, Gavin Carr, et al.. (2024). Lenacapavir Exhibits Atropisomerism—Mechanistic Pharmacokinetics and Disposition Studies of Lenacapavir Reveal Intestinal Excretion as a Major Clearance Pathway. Journal of Pharmacology and Experimental Therapeutics. 391(1). 91–103. 6 indexed citations
5.
Bekerman, Elena, Stephen R. Yant, Laurie A. VanderVeen, et al.. (2023). Long-acting lenacapavir acts as an effective preexposure prophylaxis in a rectal SHIV challenge macaque model. Journal of Clinical Investigation. 133(16). 8 indexed citations
6.
Lu, Bing, Jie Chen, Yuqing Li, et al.. (2022). Histone H3K36me2 demethylase KDM2A promotes bladder cancer progression through epigenetically silencing RARRES3. Cell Death and Disease. 13(6). 547–547. 20 indexed citations
7.
Lu, Bing, et al.. (2021). LncRNA PCAT29 Up-Regulates the Expression of PTEN by Down-Regulating miR-494 in Non-Small-Cell Lung Cancer to Suppress Tumor Progression. Critical Reviews in Eukaryotic Gene Expression. 31(6). 9–15. 8 indexed citations
8.
Huang, Xiaojia, Xinru You, Bing Lu, et al.. (2020). Nanoparticle enhanced combination therapy for stem-like progenitors defined by single-cell transcriptomics in chemotherapy-resistant osteosarcoma. Signal Transduction and Targeted Therapy. 5(1). 196–196. 52 indexed citations
9.
Wang, Ting, Darius Babusis, Yeojin Park, et al.. (2020). Species differences in liver accumulation and metabolism of nucleotide prodrug sofosbuvir. Drug Metabolism and Pharmacokinetics. 35(3). 334–340. 13 indexed citations
10.
Lin, Bo, Bing Lu, Zhen Liang, et al.. (2020). Synergy of GSK-J4 With Doxorubicin in KRAS-Mutant Anaplastic Thyroid Cancer. Frontiers in Pharmacology. 11. 632–632. 9 indexed citations
11.
Lu, Bing, Yangyang He, Jincan He, et al.. (2019). Epigenetic Profiling Identifies LIF as a Super-enhancer-Controlled Regulator of Stem Cell–like Properties in Osteosarcoma. Molecular Cancer Research. 18(1). 57–67. 35 indexed citations
12.
He, Jincan, Bo Lin, Zhen Liang, et al.. (2019). H3K27me3 loss plays a vital role in CEMIP mediated carcinogenesis and progression of breast cancer with poor prognosis. Biomedicine & Pharmacotherapy. 123. 109728–109728. 30 indexed citations
13.
Sun, Li, C.M. Chavez-Eng, Kerry L. Fillgrove, et al.. (2019). Toward Highly Sensitive and Reproducible LC–MS/MS Analysis of MK-8591 Phosphorylated Anabolites in Human Peripheral Blood Mononuclear Cells. Bioanalysis. 11(4). 233–250. 8 indexed citations
14.
Lu, Bing, Lunbiao Cui, Chao Shi, et al.. (2019). Outbreak of Vaccinia Virus Infection from Occupational Exposure, China, 2017. Emerging infectious diseases. 25(6). 1192–1195. 10 indexed citations
15.
Mo, Jingxin, Xiaojia Huang, Bing Lu, et al.. (2017). Multifunctional nanoparticles for co-delivery of paclitaxel and carboplatin against ovarian cancer by inactivating the JMJD3-HER2 axis. Nanoscale. 9(35). 13142–13152. 42 indexed citations
16.
Lu, Bing, Xiaojia Huang, Jingxin Mo, & Wei Zhao. (2016). Drug Delivery Using Nanoparticles for Cancer Stem-Like Cell Targeting. Frontiers in Pharmacology. 7. 84–84. 62 indexed citations
17.
Zhou, Yongning, Jing Wu, Zhiyi Zhang, et al.. (2010). Clinicopathological significance of E-cadherin, VEGF, and MMPs in gastric cancer. Tumor Biology. 31(6). 549–558. 43 indexed citations
18.
Prueksaritanont, Thomayant, Yuhsin Kuo, Cuyue Tang, et al.. (2006). In Vitro and in Vivo CYP3A64 Induction and Inhibition Studies in Rhesus Monkeys: A Preclinical Approach for CYP3A-Mediated Drug Interaction Studies. Drug Metabolism and Disposition. 34(9). 1546–1555. 22 indexed citations
19.
20.
Xu, Jian-Ming, et al.. (2003). Characterization of sequence-dependent synergy between ZD1839 (‘Iressa’) and oxaliplatin. Biochemical Pharmacology. 66(4). 551–563. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marit Liland Sandvold Breakdown of academic impact, for papers by Florence Gattacceca Breakdown of academic impact, for papers by J. H. Beijnen Breakdown of academic impact, for papers by Lela Buckingham Breakdown of academic impact, for papers by Mukul Minocha Breakdown of academic impact, for papers by Chunmei Xie Breakdown of academic impact, for papers by Banmeet S. Anand
Rankless by CCL
2026